You access the old version of our website. Please point your browser to our new home page. Virtual high throughput screening

Virtual high throughput screening

Quantum Pharmaceuticals is pleased to offer pharmaceutical, biotech companies and research organizations a fast and accurate virtual screening of compounds for identification of prospective strong inhibitors for a given protein target. The QUANTUM technology capitalizes on a new paradigm in molecular modeling – applying quantum and molecular physics instead of statistical approaches (scoring function- like and QSAR-like methods).

The hit rate of predicted by Quantum inhibitors is about 50%, that is approximately 50% of selected by Quantum inhibitors will show high affinity in vitro!

Predictive power of QUANTUM Predictive power of QUANTUM. Case study:New FtsZ Inhibitors Case study: New Inhibitors of FtsZ - a Tuberculosis Target.

The key advantages of Quantum technology are summarized here and in the table below.

 

        QUANTUM

  STATISTICAL SCORES

Accuracy

           +

(High accuracy independently from the structure of the compound)

            +/-

(High accuracy for compounds similar to the training set; low accuracy for structurally distant molecules)

Potential to predict new classes of inhibitors

           +

(Uniformly high accuracy all over chemical space enables to identify novel classes of inhibitors)

           -

(The predictive power of the methods dramatically falls for compounds structurally distant from the training set)

False positives

          Low rate

(High selectivity due to detailed potential surface and exact thermodynamics.)

         Higher rate

(Low selectivity owing to smooth and rough potential surface.)

Other Features

Understanding the nature of protein-ligand interactions

            +

(The method calculates free binding energy components allowing to understand which interaction plays leading role in the binding)

            -

(The prediction is based on the measure of similarity, thus does not determine the magnitude of free binding energy components)

Protein flexibility

            +

(The calculations take into consideration protein flexibility)

            -

(The methods consider proteins as rigid structures, that is particularly misleading for highly flexible proteins such as nuclear hormone receptors, kinases, HIV integrase etc.)

Need for a training set

            -

            +

© Copyright 2007 Quantum Pharmaceuticals Computer Aided Drug Design, Computer Assisted Drug Design, Computer Drug Design